Board of Directors:

Lily Lam, M.S., MBA Director

Lily Lam joined Covington in November 2000. Her responsibilities include assessing new business opportunities, negotiating and structuring transactions and actively advising investee companies in a variety of sectors including healthcare, media, software and service.

Prior to joining Covington, Lily held various research and management positions within several early-stage healthcare companies where she provided expertise in finance, operations and strategic direction. Lily holds an MBA from York University with a specialization in Strategic Management. She also holds a Master of Science from the Department of Immunology at the University of Toronto.

Lily currently sits as a Director on the Boards of BTE Technologies Inc., Interface Biologics Inc., Trillium Therapeutics Inc., Cytochroma Inc., Zelos Therapeutics Inc. and Bedlam Games Inc. as well as holding an observer position on the Boards of Adventus Remediation Technologies, Neuraxon Inc., Natrix Separations Inc., iStopover Inc., and Affinium Pharmaceuticals Inc.